160 related articles for article (PubMed ID: 25132887)
21. Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox).
Reddy VS; Bui QT; Jacobs JR; Begelman SM; Miller DP; French WJ;
Am J Cardiol; 2015 Mar; 115(5):557-62. PubMed ID: 25727079
[TBL] [Abstract][Full Text] [Related]
22. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
Handelsman Y; Shapiro MD
Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
[TBL] [Abstract][Full Text] [Related]
23. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
24. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
Kazerooni R; Watanabe JH; Bounthavong M
Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
[TBL] [Abstract][Full Text] [Related]
25. Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemia.
Capuzzi DM; Morgan JM; Carey CM; Intenzo C; Tulenko T; Kearney D; Walker K; Cressman MD
Prev Cardiol; 2004; 7(4):176-81. PubMed ID: 15539964
[TBL] [Abstract][Full Text] [Related]
26. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
27. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
Davidson MH; Donovan JM; Misir S; Jones MR
Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
[TBL] [Abstract][Full Text] [Related]
28. Lipid Profile of Patients with Acute Myocardial Infarction (AMI).
Kumar N; Kumar S; Kumar A; Shakoor T; Rizwan A
Cureus; 2019 Mar; 11(3):e4265. PubMed ID: 31139524
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia.
King JM; Crouse JR; Terry JG; Morgan TM; Spray BJ; Miller NE
Am J Med; 1994 Oct; 97(4):323-31. PubMed ID: 7942933
[TBL] [Abstract][Full Text] [Related]
30. Variability in lipid profile in patients with acute myocardial infarction from two tertiary care hospitals in Pakistan.
Iqbal MP; Shafiq M; Mehboobali N; Iqbal SP; Abbasi K
J Pak Med Assoc; 2004 Nov; 54(11):544-9. PubMed ID: 15623178
[TBL] [Abstract][Full Text] [Related]
31. The therapeutic role of niacin in dyslipidemia management.
Boden WE; Sidhu MS; Toth PP
J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):141-58. PubMed ID: 24363242
[TBL] [Abstract][Full Text] [Related]
32. The SLIM Study: Slo-Niacin® and Atorvastatin Treatment of Lipoproteins and Inflammatory Markers in Combined Hyperlipidemia.
Knopp RH; Retzlaff BM; Fish B; Dowdy A; Twaddell B; Nguyen T; Paramsothy P
J Clin Lipidol; 2009; 3(3):167-178. PubMed ID: 20046930
[TBL] [Abstract][Full Text] [Related]
33. Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.
Karas RH; Kashyap ML; Knopp RH; Keller LH; Bajorunas DR; Davidson MH
Am J Cardiovasc Drugs; 2008; 8(2):69-81. PubMed ID: 18422390
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia. Collaborative Atorvastatin Study Group.
McKenney JM; McCormick LS; Weiss S; Koren M; Kafonek S; Black DM
Am J Med; 1998 Feb; 104(2):137-43. PubMed ID: 9528731
[TBL] [Abstract][Full Text] [Related]
35. [Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study].
González-Juanatey JR; Cordero A; Vitale GC; González-Timón B; Mazón P; Bertomeu V
Rev Esp Cardiol; 2011 Oct; 64(10):862-8. PubMed ID: 21835533
[TBL] [Abstract][Full Text] [Related]
36. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
[TBL] [Abstract][Full Text] [Related]
37. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
38. Practical management of dyslipidemia with elevated lipoprotein(a).
Riche DM; East HE; Priest HM
J Am Pharm Assoc (2003); 2008; 48(6):803-7. PubMed ID: 19019811
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and tolerability of adding ezetimibe to niacin-based regimens for treatment of primary hyperlipidemia.
Jelesoff NE; Ballantyne CM; Xydakis AM; Chiou P; Jones PH; Guyton JR
Endocr Pract; 2006; 12(2):159-64. PubMed ID: 16690463
[TBL] [Abstract][Full Text] [Related]
40. Effects of adding extended-release niacin and colesevelam to statin therapy on lipid levels in subjects with atherosclerotic disease.
Moore A; Phan BA; Challender C; Williamson J; Marcovina S; Zhao XQ
J Clin Lipidol; 2007 Dec; 1(6):620-5. PubMed ID: 21291704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
